Table 1 Patient characteristics
From: Impact of attenuation correction on clinical [18F]FDG brain PET in combined PET/MRI
Patient | Age | Gender | Activity | PET/CT | PET/MRI | Imaging diagnosis |
|---|---|---|---|---|---|---|
[years] | [MBq] | [min p.i.] | [min p.i.] | |||
1 | 70 | M | 245 | 38 | 98 | Supranuclear palsy |
2 | 68 | F | 221 | 127 | 35 | Unremarkable |
3 | 57 | F | 215 | 140 | 40 | Posterior cortical atrophy DD Alzheimer’s dementia |
4 | 73 | F | 241 | 164 | 35 | Unremarkable |
5 | 53 | M | 248 | 30 | 73 | Unremarkable |
6 | 74 | F | 220 | 119 | 31 | Unremarkable |
7 | 72 | F | 222 | 55 | 85 | Unremarkable |
8 | 27 | M | 217 | 30 | 78 | Unremarkable |
9 | 79 | M | 312 | 134 | 44 | Alzheimer’s dementia |
10 | 60 | M | 210 | 131 | 30 | Frontotemporal lobar degeneration |
11 | 65 | F | 258 | 31 | 84 | Corticobasal degeneration |
12 | 65 | F | 211 | 30 | 86 | Unremarkable |
13 | 67 | M | 334 | 69 | 163 | Unremarkable |